Alvesco Side Effect Profile May Give Edge Among Corticosteroids
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Aventis and Altana are hoping Alvesco’s similar rate of oropharyngeal side effects to placebo will help the agent penetrate the inhaled corticosteroid market.